Cardiovascular Implants

Cardiovascular Implants

Global Cardiovascular Implants Market to Reach $33 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Cardiovascular Implants estimated at US$23.7 Billion in the year 2020, is projected to reach a revised size of US$33 Billion by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027. Stents, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$14.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the ICD segment is readjusted to a revised 3.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $7 Billion, While China is Forecast to Grow at 4.5% CAGR

The Cardiovascular Implants market in the U.S. is estimated at US$7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.8 Billion by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.Heart Valve Segment to Record 6% CAGR

In the global Heart Valve segment, USA, Canada, Japan, China and Europe will drive the 6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.6 Billion in the year 2020 will reach a projected size of US$3.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 29 Featured) -

  • Abbott Laboratories
  • AMG International
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Dimensions Pty. Ltd.
  • Cardiac Science Corporation
  • Edwards Lifesciences Corporation
  • Japan Lifeline Co., Ltd.
  • Medtronic PLC
  • QualiMed Innovative Medizinprodukte GmbH
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Cardiovascular Implants – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Cardiovascular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Cardiovascular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Cardiovascular Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for ICD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Heart Valve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Heart Valve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Heart Valve by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Implanted Cardiac Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Implanted Cardiac Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Implanted Cardiac Pacemaker by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for CRT Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for CRT Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for CRT Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 19: World Cardiovascular Implants Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 21: USA Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 22: USA 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
CANADA
TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 24: Canada Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 25: Canada 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
JAPAN
Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 26: Japan Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 27: Japan Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 28: Japan 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
CHINA
Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 29: China Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 30: China Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 31: China 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
EUROPE
Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 32: Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 33: Europe Historic Review for Cardiovascular Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 34: Europe 15-Year Perspective for Cardiovascular Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 35: Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 36: Europe Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 37: Europe 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
FRANCE
Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 38: France Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 39: France Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 40: France 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
GERMANY
Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 41: Germany Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 42: Germany Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 43: Germany 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
ITALY
TABLE 44: Italy Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 45: Italy Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 46: Italy 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
UNITED KINGDOM
Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 47: UK Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 48: UK Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 49: UK 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 51: Rest of Europe Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 52: Rest of Europe 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 54: Asia-Pacific Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 55: Asia-Pacific 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 56: Rest of World Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 57: Rest of World Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 58: Rest of World 15-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2012, 2021 & 2027
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings